Release Date: 26/08/22 09:49 Summary: FY22 Results Release Cover Note Price Sensitive: No Download Document 255.54KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%